KIT and gastrointestinal stromal tumor: We believe this model can be adopted to generate new GIST models (i.e., KIT exon 9 mutants, PDGFRα mutants, and BRAFV600E mutants), as well as tumors from non-gastric sites such as the small bowel, colon, rectum, esophagus, liver, and peritoneum.